share_log

Advaxis (NASDAQ:ADXS) Research Coverage Started at StockNews.com

Advaxis (NASDAQ:ADXS) Research Coverage Started at StockNews.com

Advaxis(纳斯达克股票代码:ADXS)的研究报道从 StockNews.com
Defense World ·  2023/03/06 16:53

Investment analysts at StockNews.com initiated coverage on shares of Advaxis (NASDAQ:ADXS – Get Rating) in a research report issued on Monday. The firm set a "sell" rating on the stock.

StockNews.com的投资分析师开始报道以下股票 Advaxis(纳斯达克股票代码:ADXS — 获取评级) 在周一发布的研究报告中。该公司对该股设定了 “卖出” 评级。

Advaxis Price Performance

Advax 价格表现

Shares of NASDAQ ADXS opened at $1.73 on Monday. Advaxis has a 1 year low of $1.00 and a 1 year high of $11.18.

周一,纳斯达克ADXS的股票开盘价为1.73美元。Advaxis创下1年低点1.00美元,1年高点为11.18美元。

Get
获取
Advaxis
Advax
alerts:
警报:

Advaxis Company Profile

Advaxis 公司简介

(Get Rating)

(获取评级)

Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy.

Advaxis, Inc是一家生物技术公司,从事癌症免疫疗法的发现、开发和商业化。它管理的平台技术利用活的减毒单核细胞增生李斯特菌分泌抗原或辅助融合蛋白。该公司拥有四个处于不同临床和临床前开发阶段的特许经营权,即:人乳头瘤病毒相关癌症、前列腺癌、新抗原疗法和热点突变疗法。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on Advaxis (ADXS)
  • MarketBeat Week in Review – 2/27 – 3/3
  • The 3 Most Upgraded Stocks Are Reversing
  • How to Find Blue Chip Dividend Stocks
  • Zscaler, Inc Plummets, Is It Time To Buy The Dip?
  • What is a Good Dividend Yield? How to Decide
  • 免费获取 StockNews.com 关于 Advaxis (ADXS) 的研究报告的副本
  • MarketBeat Week 回顾 — 2 月 27 日 — 3 月 3 日
  • 升级幅度最高的三只股票正在逆转
  • 如何找到蓝筹股股息股
  • Zscaler, Inc. 暴跌,是时候逢低买入了吗?
  • 什么是良好的股息收益率?如何决定

Receive News & Ratings for Advaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advaxis and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收 Advaxis 的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Advaxis及相关公司的最新新闻和分析师评级的简明每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发